Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Systemic Therapy with Infectivity-Selective Oncolytic Adenovirus for PDAC
RDoC Constructs: Neural Substrates, Heritability, and Relation to Psychopathology
A Comprehensive System for Microarray Data Analysis
Probes for Flow Cytometry
Prenatal Thymic Radiation Injury and Immune Development
Recently added grants:
Cross talk between epithelial, inflammatory and mesenchymal cells in the development of portal fibrosis
Neighborhoods, Networks, and the HIV Care Continuum among HIV-infected MSM in NYC
Biotyping placebo and treatment-specific responses for precision medicine
Program to promote lung regeneration and block fibrosis
3? End Regulation in Nociceptor Plasticity
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB67190-2-0-1
Application #
7574870
Study Section
Project Start
2006-09-30
Project End
2009-12-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/ Albert Einstein College of Medicine
$396,788
NIH 2007
N01 HL
Sildenafil for Sickle Cell Disease-Associated Pulmonary Hypertension
Little, Jane /
$471,185
NIH 2007
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/
NIH 2007
N01 HL
/
Comments
Be the first to comment on this grant
